Thermo Fisher Scientific (TMO) Depreciation & Amortization (CF) (2009 - 2018)

Thermo Fisher Scientific has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $331.0 million in Q2 2026.

• Depreciation & Amortization (CF) for Q2 2026 came in at $331.0 million, up 29.3% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.2 billion (up 2.57% YoY), and the FY2025 annual result was $1.0 billion, down 9.17% from the prior year.
• Depreciation & Amortization (CF) improved to $331.0 million in Q2 2026, from $306.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $331.0 million in Q2 2026 and troughed at $227.0 million in Q3 2025.
• A 5-year average of $272.1 million and a median of $273.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The widest annual swing landed in 2025, when Depreciation & Amortization (CF) decreased 21.99%; it then grew 29.3% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $256.0 million in 2022, then advanced by 7.81% to $276.0 million in 2023, then advanced by 10.14% to $304.0 million in 2024, then dropped by 3.95% to $292.0 million in 2025, then advanced by 13.36% to $331.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $331.0 million in Q2 2026, $306.0 million in Q1 2026, and $292.0 million in Q4 2025.